Clinical Trial Update: Efficacy, Safety and Tolerability of Romosozumab in the Treatment of Japanese Women With Postmenopausal Osteoporosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing efficacy, safety, and tolerability of Romosozumab in Japanese women with postmenopausal osteoporosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Romosozumab (romosozumab)

Snippet

Sponsor: Amgen | Conditions: Postmenopausal Osteoporosis (PMO) | Phase 2 | Status: COMPLETED | Results posted: 2019-03-25